These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2458015)

  • 1. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
    Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H; Greenstein A; Kaver I; Braf Z
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
    Jenkins D; Jones RT; Clarke AM
    Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
    Rubenstein M; Guinan PD; McKiel CF; Dubin A
    Clin Physiol Biochem; 1988; 6(5):241-52. PubMed ID: 2465864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 9. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of prostate-specific antigen during external beam radiotherapy for carcinoma of the prostate.
    van Eijkeren M; van Haelst JP
    Strahlenther Onkol; 1990 Aug; 166(8):557-61. PubMed ID: 1697702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of PSA in prostatic adenocarcinoma].
    Manca GP
    Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory studies for the detection of carcinoma of the prostate.
    Brawer MK
    Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers in monitoring the treatment of advanced prostate cancer.
    Cooper EH; Armitage TG
    Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
    Tarle M
    Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
    Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
    Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.